Literature DB >> 32877239

Developmental programming of peripheral diseases in offspring exposed to maternal obesity during pregnancy.

Nirajan Shrestha1, Henry C Ezechukwu2, Olivia J Holland1,3, Deanne H Hryciw4,5,6.   

Abstract

Obesity is an increasing global health epidemic that affects all ages, including women of reproductive age. During pregnancy, maternal obesity is associated with adverse pregnancy outcomes that lead to complications for the mother. In addition, maternal obesity can increase the risk of poor perinatal outcomes for the infant due to altered development. Recent research has investigated the effects of maternal obesity on peripheral organ development and health in later life in offspring. In this review, we have summarized studies that investigated the programming effects of maternal obesity before and during pregnancy on metabolic, cardiovascular, immune, and microbiome perturbations in offspring. Epidemiological studies investigating the effects of maternal obesity on offspring development can be complex due to other copathologies and genetic diversity. Animal studies have provided some insights into the specific mechanisms and pathways involved in programming peripheral disease risk. The effects of maternal obesity during pregnancy on offspring development are often sex specific, with sex-specific changes in placental transport and function suggestive that this organ is likely to play a central role. We believe that this review will assist in facilitating future investigations regarding the underlying mechanisms that link maternal obesity and offspring disease risk in peripheral organs.

Entities:  

Keywords:  fetal programming; maternal overnutrition; obesity; peripheral diseases

Mesh:

Year:  2020        PMID: 32877239     DOI: 10.1152/ajpregu.00214.2020

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  7 in total

Review 1.  Maternal weight and gestational diabetes impacts on child health.

Authors:  Kathryn V Dalrymple; Sarah El-Heis; Keith M Godfrey
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2022-02-23       Impact factor: 3.620

2.  Perinatal Obesity Induces Hepatic Growth Restriction with Increased DNA Damage Response, Senescence, and Dysregulated Igf-1-Akt-Foxo1 Signaling in Male Offspring of Obese Mice.

Authors:  Philipp Kasper; Jaco Selle; Christina Vohlen; Rebecca Wilke; Celien Kuiper-Makris; Oleksiy Klymenko; Inga Bae-Gartz; Charlotte Schömig; Alexander Quaas; Björn Schumacher; Münevver Demir; Martin Bürger; Sonja Lang; Anna Martin; Hans-Michael Steffen; Tobias Goeser; Jörg Dötsch; Miguel A Alejandre Alcazar
Journal:  Int J Mol Sci       Date:  2022-05-17       Impact factor: 6.208

3.  Effects of exogenous adiponectin supplementation in early pregnant PCOS mice on the metabolic syndrome of adult female offspring.

Authors:  Meng Zuo; Guotao Liao; Wenqian Zhang; Dan Xu; Juan Lu; Manhong Tang; Yue Yan; Chenghao Hong; Yuxia Wang
Journal:  J Ovarian Res       Date:  2021-01-18       Impact factor: 4.234

4.  Development of Obesity: The Driver and the Passenger.

Authors:  Wolfgang Kopp
Journal:  Diabetes Metab Syndr Obes       Date:  2020-11-27       Impact factor: 3.168

5.  Effect of a dietary and exercise intervention in women with overweight and obesity undergoing fertility treatments: protocol for a randomized controlled trial.

Authors:  Kindann Fawcett; Audrey Martinez; Meghan Crimmins; Clark Sims; Elisabet Børsheim; Aline Andres
Journal:  BMC Nutr       Date:  2021-08-17

6.  Male Rat Offspring Are More Impacted by Maternal Obesity Induced by Cafeteria Diet than Females-Additive Effect of Postweaning Diet.

Authors:  Aynaz Tajaddini; Michael D Kendig; Kelly V Prates; R Frederick Westbrook; Margaret J Morris
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

7.  DNA methylation profiles in the blood of newborn term infants born to mothers with obesity.

Authors:  Aya Sasaki; Kellie E Murphy; Laurent Briollais; Patrick O McGowan; Stephen G Matthews
Journal:  PLoS One       Date:  2022-05-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.